Published in Drug Week, December 2nd, 2005
Earlier, an FDA advisory committee recommended approval of Exubera for the treatment of adults with type 1 and type 2 diabetes. FDA is not obligated to follow the advisory committee's recommendation. Pfizer and sanofi-aventis continue to work closely with the FDA so that this important...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.